Edit
Acura Pharmaceuticals, Inc.
http://www.acurapharm.com/?portfolioCats=34,23,29,35,22,24,30,25,28,31#new_tabLast activity: 01.03.2022
Active
Acura and King are developing Acurox® (oxycodone HCl) Tablets (without niacin) intended to relieve moderate to severe pain and to introduce limits and
Location: United States, Illinois, Palatine
Investors 3
| Date | Name | Website |
| - | Galen Part... | galen.com |
| 14.05.2021 | EW Healthc... | ewhealthca... |
| - | Vivo Capit... | vivocapita... |
Mentions in press and media 8
| Date | Title | Description |
| 01.03.2022 | Acura Pharmaceuticals and AD Pharma Amend License to LIMITx™ LTX-03 | PALATINE, Ill., March 01, 2022 (GLOBE NEWSWIRE) -- Acura Pharmaceuticals, Inc. (OTCQB: ACUR) today announced an amendment to its License, Development and Commercialization Agreement (“Agreement”) regarding Acura’s LIMITx™ LTX-03 product can... |
| 29.12.2021 | Acura Pharmaceuticals, Inc. Receives $150,000 Loan from John Schutte | On December 21, 2021, Acura Pharmaceuticals, Inc., received a $150,000 loan from John Schutte. In connection with the $150,000 loan, issued an unsecured promissory note, or the Schutte Note, in that principal amount to him. The Schutte Note... |
| 16.11.2021 | Acura Pharmaceuticals Announces Third Quarter 2021 Financial Results | PALATINE, Ill., Nov. 15, 2021 (GLOBE NEWSWIRE) -- Acura Pharmaceuticals, Inc. (OTCQB: ACUR), an innovative drug delivery company engaged in the research, development and commercialization of technologies and products intended to address saf... |
| 15.11.2021 | Acura Pharmaceuticals Announces Third Quarter 2021 Financial Results | PALATINE, Ill., Nov. 15, 2021 (GLOBE NEWSWIRE) -- Acura Pharmaceuticals, Inc. (OTCQB: ACUR), an innovative drug delivery company engaged in the research, development and commercialization of technologies and products intended to address saf... |
| 16.08.2021 | Acura Pharmaceuticals Announces Second Quarter 2021 Financial Results | PALATINE, Ill., Aug. 16, 2021 (GLOBE NEWSWIRE) -- Acura Pharmaceuticals, Inc. (OTCQB: ACUR), an innovative drug delivery company engaged in the research, development and commercialization of technologies and products intended to address saf... |
| 14.06.2021 | ACURA PHARMACEUTICALS, INC. Acura Pharmaceuticals Announces Conversion of Debt | PALATINE, Ill., June 14, 2021 (GLOBE NEWSWIRE) -- Acura Pharmaceuticals, Inc. (OTCQB: ACUR) today announced that Abuse Deterrent Pharma, LLC (“AD Pharma”) has converted the entire principle and accrued interest of its Secured Promissory Not... |
| 17.05.2021 | ACURA PHARMACEUTICALS, INC. Acura Pharmaceuticals Announces First Quarter Ended March 31, 2021 Financial Results | PALATINE, Ill., May 17, 2021 (GLOBE NEWSWIRE) -- Acura Pharmaceuticals, Inc. (OTCQB: ACUR), an innovative drug delivery company engaged in the research, development and commercialization of technologies and products intended to address safe... |
| 31.03.2021 | ACURA PHARMACEUTICALS, INC. Acura Pharmaceuticals Announces Fourth Quarter and Full Year 2020 Financial Results | PALATINE, Ill., March 31, 2021 (GLOBE NEWSWIRE) -- Acura Pharmaceuticals, Inc. (OTCQB: ACUR), an innovative drug delivery company engaged in the research, development and commercialization of technologies and products intended to address sa... |